戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n that can develop after cataract surgery or intraocular injection.
2 duced permeability and edema formation after intraocular injection.
3 eyedrop is non-toxic and eliminates need for intraocular injection.
4 mercially available antibiotic indicated for intraocular injection.
5 the retina for almost 1 month after a single intraocular injection.
6 mplement in the induction of tolerance after intraocular injection.
7 treatments, thereby minimizing the number of intraocular injections.
8 iseases, but such therapies require repeated intraocular injections.
9 778 15 mg twice per day (BID) + monthly sham intraocular injections; (2) combination therapy: subcuta
10                        The average number of intraocular injections administered before aflibercept i
11  may avoid the complications associated with intraocular injection and systemic administration.
12                             Six months after intraocular injections and EAE sensitization, combinatio
13 local intervention by topical application or intraocular injection; and (iv) real-time tracking of in
14 op dosing regimens and the need for frequent intraocular injections are significant barriers to effec
15 Nonetheless, optimal visual outcomes require intraocular injections as frequently as every month.
16 only 30-60% of patients and require multiple intraocular injections associated with iatrogenic infect
17  patient acceptance and lower morbidity than intraocular injection, but many ophthalmic treatments ar
18 vascularization (ROR 1328, 95% CI 956-1845), intraocular injection complication (ROR 2552, 95% CI 160
19 es involving administration by inhalation or intraocular injection could result in very low but susta
20 ing high treatment burden requiring repeated intraocular injections for persistent disease.
21 tions like globe penetration and inadvertent intraocular injection have been reported.
22 nd Abeta40 peptides fused to BRI2 protein by intraocular injection in C57BL/6J mice.
23          Eyes were excluded if they received intraocular injections, laser procedures, new immunosupp
24                                     A single intraocular injection of 0.4 mg MP0112 resulted in level
25 re seen at least every 3 months and given an intraocular injection of 0.5 mg ranibizumab if they met
26              In contrast, 4 to 6 weeks after intraocular injection of 1.5 x 10(9) or 2.0 x 10(10) par
27                                              Intraocular injection of 150 microM zinc and treatment o
28                                              Intraocular injection of 5 ng of VEGF/rGel also caused s
29                   DA-IPCs were destroyed via intraocular injection of 6-hydroxydopamine over 2 succes
30 munoprecipitation of IRBP labeled in vivo by intraocular injection of [(35)S]methionine.
31                                     Further, intraocular injection of a TGFbeta3-neutralizing antiser
32                                              Intraocular injection of AAQ restores the pupillary ligh
33                      Four to six weeks after intraocular injection of AAV-CBA-PEDF, levels of PEDF in
34                                              Intraocular injection of AAV5-IRBP/GNAT2-Syvn1 resulted
35                                              Intraocular injection of activin A or follistatin (300 n
36              In a blind patient, we combined intraocular injection of an adeno-associated viral vecto
37                                     A single intraocular injection of an adenovirus encoding both the
38                                              Intraocular injection of an adenovirus vector (AdCMV-PAI
39 iferation and tube-forming capacity, whereas intraocular injection of an antagomir targeting miR-132,
40                                              Intraocular injection of an anti-VE-PTP antibody previou
41              Neonatal rats were treated with intraocular injection of an antisense oligonucleotide (1
42                                              Intraocular injection of an irreversible caspase-3 inhib
43                                              Intraocular injection of anti-VCAM-1 antibody eliminated
44 mined one day before and one month after the intraocular injection of bevacizumab.
45 vely inhibiting VEGF-A binding to FN through intraocular injection of blocking peptides.
46 ections were visualized and mapped following intraocular injection of cholera toxin B subunit.
47                                    Following intraocular injection of cholera toxin subunit B (CTB),
48                                    Following intraocular injection of cholera toxin subunit B (CTB),
49                                              Intraocular injection of ciliary neurotrophic factor mim
50                                              Intraocular injection of collagenase led to the disrupti
51 after disrupting the retinal basal lamina by intraocular injection of collagenase.
52                                     A single intraocular injection of DENAQ photosensitizes the blind
53 sociates tissues, the hypothesis was that an intraocular injection of dispase could trigger events th
54                                              Intraocular injection of DXR-PSA-PEG3 nanoparticles (1 o
55 ic mice that express VEGF in photoreceptors, intraocular injection of DXR-PSA-PEG3 nanoparticles (10
56                                              Intraocular injection of DXR-PSA-PEG3 nanoparticles (2.7
57                                              Intraocular injection of exogenous protein induces an Ag
58 H-P was increased markedly by light or after intraocular injection of GABA(A) and glycine inhibitors.
59 neration may not be amenable to treatment by intraocular injection of LEDGF.
60                                              Intraocular injection of linezolid, a synthetic oxazolid
61                            Here we show that intraocular injection of lipopolysaccharide (LPS), a bac
62                                 In addition, intraocular injection of ManN induces retinal neovascula
63                                              Intraocular injection of microbeads was made in mouse ey
64 o blindness 8 mo after birth was reversed by intraocular injection of MTS-AAV expressing wild-type hu
65 estigated the effects of surgical injury and intraocular injection of neurotrophic factors on the mit
66  occurs after ischemia/reperfusion and after intraocular injection of NMDA or kainate, can be followe
67                     After its destruction by intraocular injection of ouabain, the goldfish retina re
68  similar to the regulatory T cells evoked by intraocular injection of OVA.
69 a1 caused robust stimulation of KCa, whereas intraocular injection of pan-TGFbeta antiserum inhibited
70 ring expression of DH were induced by either intraocular injection of peptide or i.v. injection of AP
71 protein Ag and adjuvant was suppressed after intraocular injection of protein Ag administered either
72                                  Conversely, intraocular injection of recombinant vasohibin or an ade
73                                              Intraocular injection of rhVEGF-A(165)b gave a pronounce
74                                              Intraocular injection of rodent eyes with the recombinan
75 ochemical studies revealed that following an intraocular injection of SNP retinal photoreceptors are
76                  Immune deviation induced by intraocular injection of soluble protein Ag, referred to
77           Acute retinal activity blockade by intraocular injection of tetrodotoxin (TTX) rapidly and
78                                              Intraocular injection of TGFbeta1 caused robust stimulat
79                                              Intraocular injection of TGFbeta3 causes a modest but si
80                                              Intraocular injection of the Bartha strain of pseudorabi
81                                              Intraocular injection of the constructs into the mouse m
82                                              Intraocular injection of the dectin-1 ligand curdlan [a
83                                     A single intraocular injection of the immunotoxin caused a rapid,
84 When we chemically blocked ATF6 signaling by intraocular injection of the small molecule Ceapin-A7, w
85                                              Intraocular injection of the uveitogenic peptide (IRBP1-
86                                        After intraocular injection of the virulent pseudorabies virus
87 ncluding laser photocoagulation and repeated intraocular injection of VEGF antagonists, are invasive
88                                        After intraocular injection of VEGF into both eyes, topical pa
89 sed by pericyte depletion are phenocopied by intraocular injection of VEGF-A or pericyte-specific ina
90 t MAC was present in the normal rat eye, and intraocular injection of zymosan induced severe anterior
91                                      We made intraocular injections of 2-amino-4-phosphonobutyric aci
92 ls were killed 12 hr to 2 weeks later, after intraocular injections of anterograde tracers to label t
93 timated for each case at adulthood, by using intraocular injections of anterograde tracers.
94 licular pathway observed in fetal cats after intraocular injections of anterograde tracers.
95                       Mice were treated with intraocular injections of anti-c-Met antibody, and the e
96                                       Direct intraocular injections of anti-CMV drugs and the sustain
97             Current therapy includes monthly intraocular injections of anti-VEGF antibodies, which ar
98 ople, and is currently treated with frequent intraocular injections of anti-VEGF protein.
99 ion vitrectomy surgery (MIVS) that omits any intraocular injections of antibiotics or steroids.
100 ular immune deviation studies have relied on intraocular injections of antigen to induce altered immu
101          From month 6, all patients received intraocular injections of bevacizumab every 6 weeks for
102                                              Intraocular injections of bevacizumab given every 6 week
103                                              Intraocular injections of bevacizumab given every 6 week
104 ine, patients were randomized 1:1 to receive intraocular injections of bevacizumab or sham injections
105 oreduction, intra-arterial chemotherapy, and intraocular injections of chemotherapeutic agents were s
106 hilean Tinamou (Nothoprocta perdicaria) that intraocular injections of Cholera Toxin B subunit retrog
107                                              Intraocular injections of DXR or DNR suppressed choroida
108                                              Intraocular injections of glucagon completely prevented
109                                              Intraocular injections of glucagon or GLP1 suppressed th
110 FGFs, in the current study we tested whether intraocular injections of growth factors stimulate Mulle
111 ansitin in mature Muller glia was induced by intraocular injections of insulin and fibroblast growth
112                                We found that intraocular injections of insulin, EGF, or FGF2 stimulat
113                 Blocking retinal activity by intraocular injections of muscimol or gabazine during th
114 eir endothelial cells were sedated and small intraocular injections of PBS were made into one eye and
115 were treated with systemic chemotherapy plus intraocular injections of rituximab or methotrexate sodi
116 g with 24 hours of 10% oxygen, pups received intraocular injections of SRPIN340, vehicle, VEGF165b, a
117 ated activity on this developmental process, intraocular injections of tetrodotoxin (TTX) were made d
118 f periods of monocular deprivation caused by intraocular injections of tetrodotoxin leading to a 30%
119                             Laser treatment, intraocular injections of triamcinolone or a vascular en
120 udy, the authors investigated the effects of intraocular injections of type 2 scAAV.GFP in mice.
121                                              Intraocular injections of vascular endothelial growth fa
122                                    Long-term intraocular injections of vascular endothelial growth fa
123 itating continued neutralization by repeated intraocular injections of VEGF antagonists in many patie
124 icipate in the development of retinal NV and intraocular injections of VEGF antagonists only partiall
125                                        Large intraocular injections of WGA-HRP were placed into the e
126 olumns (ODCs) revealed transneuronally after intraocular injections of wheat germ agglutinin-horserad
127 tivation appears to play a key role, because intraocular injections of Zymosan, a yeast cell wall pre
128                           Systemic delivery, intraocular injection or topical application of putative
129 ser photocoagulation, vitreoretinal surgery, intraocular injection, or a combination thereof.
130 eated by laser photocoagulation and multiple intraocular injections, procedures that destroy healthy
131 n alters subsequent immune responses without intraocular injection, suggesting that normal retinal pr
132 rast, axotomy, either alone or combined with intraocular injections that do not infringe on the lens,
133                              One month after intraocular injections, transgene expression increased 4
134  expression compared with that observed with intraocular injection using the same vectors at P14.
135 acks, laser trabeculoplasties, surgeries, or intraocular injections were excluded.
136 ndal injection (1), sub-Tenon injection (1), intraocular injection with vitrectomy (1), and eye drops

 
Page Top